AliveCor and Luscii join forces to introduce the Luscii Virtual Heart Clinic, a comprehensive app integrated with advanced ECG technology, blood pressure meters, and more, enabling remote cardiac patient monitoring.
Read MoreA recent analysis highlights the importance of evaluating cardiac damage after transcatheter aortic valve replacement (TAVR). The study emphasizes the need to understand the evolution of cardiac damage post-TAVR and its impact on long-term prognosis. By assessing cardiac damage within 30 days of TAVR, cardiologists can gain valuable insights for better patient management and improved outcomes.
Read More
A coroner’s report raises concerns about the prescription of ciprofloxacin and its potential link to rare side effects, including suicidal behavior. The report calls for a review of current guidelines and increased awareness among prescribing doctors to monitor and mitigate these risks.
Read More
A recent meta-analysis confirms the consistent benefits of SGLT2 inhibitors in reducing the risks of cardiovascular death and heart failure hospitalization in patients with HF, type 2 diabetes, and CKD.
Read More
A networking group for cardiology fellows-in-training has proven effective in involving trainees in clinical trial programs. This model showcases the potential to enhance diversity and representation in trials, tackling existing gaps in enrollment and promoting equal participation.
Read More